Δ-Aminolevulinate dehydratase activity in type 2 diabetic patients and its association with lipid profile and oxidative stress

Clinical Biochemistry

Volumn 44, Issue 13, 2011, Pages 1105-1109

  Bonfanti, Gabriela ^a   Ceolin, Ronise B ^a   Valcorte, Tiago ^a   De Bona, Karine S ^a   De Lucca, Leidiane ^a   Gonçalves, Thissiane L ^a   Moretto, Maria Beatriz ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Aminolevulinate dehydratase activity; Body mass index; Lipid profile; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

ASCORBIC ACID; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PORPHOBILINOGEN SYNTHASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME ACTIVITY; ENZYME REACTIVATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; LIPIDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PORPHOBILINOGEN SYNTHASE;

EID: 80051701853     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.06.980     Document Type: Article

References (50)

1. Kedziora-Kornatowska K., Szewczyk-Golec K., Kozakiewicz M., Pawluk H., Czuczejko J., Kornatowski T., et al. Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patiens. J Pineal Res 2009, 46:333-337.
2. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
3. Booth G.L., Kapral M.K., Fung K., Tu J.V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006, 368:29-36.
4. Pfaffly J.R. Review on diabetic complications. Free Radic Biol Med 2001, 77:222.
5. Narasimhan S., Gokulakrishnan K., Sampathkumar R., Farooq S., Ravikumar R., Mohan V., et al. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem 2010, 43:815-821.
6. de Bona K.S., Bellé L.P., Sari M.H., Thomé G., Schetinger M.R., Morsch V.M., et al. Syzygium cumini extract decrease adenosine deaminase, 5' nucleotidase activities and oxidative damage in platelets of diabetic patients. Cell Physiol Biochem 2010, 26:729-738.
7. Srivatsan R., Das S., Gadde R., Manoj-Kumar K., Taduri S., Rao N., et al. Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med 2009, 12:121-127.
8. Pandey K.B., Mishra N., Rizvi S.I. Protein Biomarkers in plasma of type 2 diabetic patients. Clin Biochem 2010, 43:508-511.
9. Skalska A., Gasowski J., Grodzicki T. Antioxidants modify the relationship between endothelin-1 level and glucose metabolism - associated parameters. Metabolism 2009, 58:1229-1233.
10. Ramakrishna V., Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008, 45:41-46.
11. Giugliano D., Cerrielo A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-267.
12. Farina M., Brandão R., Lara F.S., Soares F.A., Souza D.O., Rocha J.B.T. Mechanisms of the inhibitory effects of selenium and mercury on the activity of δ-aminolevulinate dehidratase from mouse liver, kidney and brain. Toxicol Lett 2003, 139:55-66.
13. Jaffe E.K., Ali S., Mitchell L.W., Taylor K.M., Volin M., Markham G.D. Characterization of the role of the stimulatory magnesium of Escherichia coli porphobilinogen synthase. Biochemistry 1995, 34:244-251.
14. Sassa S., Fujita H., Kappas A. Genetic and chemical influences on the heme biosynthesis. Highlights of modern biochemistry, V.S.P. Intl. Science 1989, 329-338. A. Kotyk (Ed.).
15. Sassa S. ALA-D porphyria. Semin Liver Dis 1998, 18:95-101.
16. Gonçalves T.L., Erthal F., Corte C.L.D., Muller L.G., Piovezan C.M., Nogueira C.W., et al. Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women. Clin Biochem 2005, 38:1071-1075.
17. Fontanellas A., Navarro S., Morán-Jiménez M.J., Sánchez-Fructuoso A.I., Vegh I., Barrientos A., et al. Erythrocyte aminolevulinate dehydratase activity as a lead marker in patients with chronic renal failure. Am J Kidney Dis 2002, 40:43-50.
18. Fernandez-Cuartero B., Rebollar J.L., Batle A., Enriquez de Salamanca R. Delta aminolevulinato dehydratase (ALA-D) activity in human and experimental diabetes mellitus. Int J Biochem Cell Biol 1999, 31:479-488.
19. Folmer V., Soares J.C., Rocha J.B.T. Oxidative stress in mice is dependent on the free glucose content of the diet. Int J Biochem Cell Biol 2002, 34:1279-1285.
20. Folmer V., Soares J.C.M., Gabriel D., Rocha J.B.T. A high-fat diet inhibits δ-aminolevulinate dehydratase and increases lipid peroxidation in mice (Mus musculus). J Nutr 2003, 133:2165-2170.
21. Caballero F.A., Gerez E.N., Polo C.F., Vazquez E.S., Batlle A.M. Reducing sugars trigger δ-aminolevulinate dehidratase inactivation: evidence of in vitro aspirin prevention. Gen Pharmacol 1998, 31:441-445.
22. Kaviarasan K., Arjunan M.M., Pugalendi K.V. Lipid Profile, oxidant-antioxidant status and glycoprotein components in hyperlipidemic patients with/without diabetes. Clin Chim Acta 2005, 362:49-56.
23. Bigaard J., Tjonneland A., Thomsen B.L., Overvad K., Heitmann B.L., Sorensen T.I. Waist circumference, BMI, smoking and mortality in middle-aged men and women. Obes Res 2003, 11:895-903.
24. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of concentration of low-density lipoprotein in plasma, without use of preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
25. [acessed]. http://Ada-http://care.diabetesjournals.org/content/34/Supplement_1/S11.full#sec-64.
26. Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults - final report 2002, 02:5215. NHI publication.
27. Berlin K., Schaller H. European standardized method for the determination of δ-aminolevulinic dehydratase activity in blood. Z Klin Chem Klin Biochem 1974, 12:389-390.
28. Lapenna D., Ciofani G., Pierdomenico S.D., Giamberardino M.A., Cuccurullo F. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 2001, 31:331-335.
29. Boyne A.F., Ellman G.L. A methodology for analysis of tissue sulfhydryl components. Anal Biochem 1972, 46:639-653.
30. Jacques-Silva M.C., Nogueira C.W., Broch L.C., Flores E.M.M., Rocha J.B.T. Dyphenyl disselenides and ascorbic acid changes deposition of selenium and brain of mice. Pharmacol Toxicol 2001, 88:119-125.
31. Galley H., Davies M.J., Webster N.R. Ascorbil radical formation in patients with sepsis: effects of ascorbate loading. Free Radic Biol Med 1996, 20:139-143.
32. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
33. Misra H.P., Fridovich I. The role of superoxide anion in autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972, 247:3170-3175.
34. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186:464-478.
35. Kannel W.B., Castelli W.P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979, 90:85-91.
36. Friedl K.E. Waist circumference threshold values for type 2 diabetes risk. J Diabetes Sci Technol 2009, 3:761-769.
37. Pereira B., Curi R., Kokobun E., Bechara E.J. 5-aminolevulinc acid-induced alterations of oxidative metabolism in sedentary and exercise-trained rats. J Appl Physiol 1992, 72:226-230.
38. Souza J.B., Rocha J.B.T., Nogueira C.W., Borges V.C., Kaizer R.R., Dressler V.L., et al. Delta aminolevulinate dehydratase (δ-ALA-D) activity in diabetes and hypothyroidism. Clin Biochem 2007, 40:321-325.
39. Soares J.C.M., Gabriel D., Folmer V., Augusti G.R., Rocha J.B.T. High concentrations of glucose can activate or inhibit human erythrocyte aminolevulinate dehydratase in vitro depending exposure time. Am J Biochem Biotechnol 2006, 2:180-185.
40. Grotto D., Valentini J., Filion M., Passos C.J., Garcia S.C., Mergler D., et al. Barbosa, Mercury exposure and oxidative stress in communities of the Brazilian Amazon. Sci Total Environ 2010, 408:806-811.
41. Folmer V., Santos F.W., Savengnago L., Britto V.B., Nogueira C.W., Rocha J.B.T. High sucrose consumption potentiates the sub-acute cadmium effect on Na+/K+-ATPase but not on delta-aminolevulinate dehydratase in mice. Toxicol Lett 2004, 153:333-341.
42. Valentini J., Grotto D., Paniz C., Rohers M., Burg G., Garcia S.C. The influence of the hemodialysis time treatment under oxidative stress biomarkers in chronic renal failure patients. Biomed Pharmacother 2008, 62:378-382.
43. Pavlatou M.G., Papastamataki M., Apostolakou F., Papassotiriou I., Tentolouris N. FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus. Metabolism 2009, 58:1657-1662.
44. Griesmacher A., Kindhauser M., Andert S.E., Schreiner W., Toma C., Knoebl P., et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995, 98:469-475.
45. McKenney J.M. Pharmacotherapy of dyslipidemia. Cardiovasc Drugs Ther 2001, 15:413-422.
46. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
47. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.
48. Pouliot M.C., Després J.P., Lemieux S., Moorjani S., Bouchard C., Tremblay A., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994, 73:460-468.
49. Tarnai I., Csordás M., Sükei E., Shemirani A.H., Káplár M., Góth L. Effect of C111T polymorphism in exon 9 of the catalase gene on blood catalase activity in different types of diabetes mellitus. Free Radic Res 2007, 41:806-811.
50. Góth L., Eaton J.W. Hereditary catalase deficiencies and increased risk of diabetes. Lancet 2000, 9244:1820-1821.